Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
125.96
-2.68 (-2.08%)
At close: Apr 28, 2026, 4:00 PM EDT
135.01
+9.05 (7.18%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Palvella Therapeutics Employees
Palvella Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 15 or 107.14% compared to the previous year.
Employees
29
Change (1Y)
15
Growth (1Y)
107.14%
Revenue / Employee
n/a
Profits / Employee
-$1,438,448
Market Cap
1.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29 | 15 | 107.14% |
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Galapagos NV | 558 |
| Vericel | 398 |
| Syndax Pharmaceuticals | 298 |
| Harmony Biosciences Holdings | 293 |
| Innoviva | 159 |
| Pharvaris | 129 |
| Inhibrx Biosciences | 110 |
PVLA News
- 8 days ago - Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026 - GlobeNewsWire
- 15 days ago - Palvella Therapeutics Appoints John D. Doux, M.D. - GlobeNewsWire
- 21 days ago - Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales - GlobeNewsWire
- 4 weeks ago - Palvella Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations - GlobeNewsWire
- 4 weeks ago - Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting - GlobeNewsWire
- 5 weeks ago - Palvella Therapeutics to Host Full Year 2025 Financial Results Conference Call and Provide a Corporate Update on March 31, 2026 - GlobeNewsWire